Researchers from the Universidade de São Paulo (USP) and ICEERS have found that ayahuasca may modulate neural networks, and suggest that more research is needed to...
Psyched Wellness has carried out a neurobehavioral study evaluating the safety and efficacy of its Amanita Muscaria extract – AME-1.
Enosis Therapeutics, OVID Clinics and the MIND Foundation for Psychedelic Research have joined together to implement the world’s first in-clinic application of Virtual Reality (VR) combined...
Between 1950 and 1965, approximately 40,000 patients were prescribed a form of LSD therapy, as a treatment for neurosis, schizophrenia and psychopathy.
Mind Medicine Australia has provided funding for two studies that will be investigating the use of psilocybin and MDMA.
Justin Townsend, CEO of MycoMeditations, explores what to look for when evaluating a psychedelic retreat if you are considering attending – from what models to consider...
Detailed brain imaging data from 20 healthy volunteers has revealed how DMT increased connectivity across the brain, with more communication between different areas and systems.
Psychedelic-assisted therapies could hit UK markets sooner than expected – and sooner than may happen in Europe – under a new government funding plan for innovative...
When psychedelic therapies begin to gain regulatory approval, they will need to be incorporated into the medical billing and coding system in a way that ensures...
Psychedelic substances, such as LSD and psilocybin, are known for their effects on the brain that can produce profound changes in perception, mood and consciousness.
In what has been described as a “historic trial”, ICEERS has suggested that the verdict of an ayahuasca trial in Mexico opens the door for the...
Breaking Convention is returning in 2023 to explore the latest groundbreaking psychedelic research and provide insights into law, politics, art, history and philosophy.